Warburg Pincus

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Mariner Finance is a Baltimore-based consumer finance company that focuses on providing tailored financial solutions to meet the specific needs of its customers. The company offers a range of products, including medium-term installment loans, personal loans, car loans, home loans, and credit insurance, primarily targeting near-prime borrowers. Mariner Finance distinguishes itself through its commitment to exceptional customer service, which is viewed as essential for building lasting relationships in the communities it serves. By prioritizing quality service and maintaining a local approach, Mariner Finance aims to not only meet but exceed the expectations of its clients, reinforcing its reputation as the preferred consumer finance company in the area.

Competitive Power Ventures Holdings, LLC (CPV) is a prominent electric power generation development and asset management company based in Silver Spring, Maryland, with additional offices in Braintree, Massachusetts, San Francisco, California, and Ontario, Canada. The company specializes in creating new clean energy supplies, focusing on combined-cycle natural gas and wind-powered generation to meet the increasing demand in high-load areas across North America. CPV has nearly 5,000 megawatts of natural gas projects in various stages of development and plans to initiate construction on approximately 1,400 megawatts in the next year, with expectations of adding another 1,200 megawatts annually. Its Asset Management division has overseen over 8,000 megawatts of generation since 2001 and currently manages 6,100 megawatts. Through its strategic approach, CPV aims to provide environmentally responsible electric power while emphasizing community values and operational expertise.

GlobalSpec, Inc. is a specialized information services and e-publishing company that caters to the engineering and manufacturing sectors. Founded in 1996 and based in East Greenbush, New York, the company provides domain-specific search engines, web-based content, and industry newsletters for users seeking information on various products and services. Its offerings encompass a wide range of product categories, including building and construction materials, electrical and electronic components, industrial equipment, and laboratory instruments. GlobalSpec also delivers filtered sales leads, product promotion, and advertising services for businesses aiming to reach their target audiences effectively. Additionally, the company offers customized marketing programs to enhance visibility and campaign performance across multiple sectors, including construction, automotive, aerospace, and life sciences. GlobalSpec operates sales offices in New York and Maryland, with media representatives in various international locations, including China, Germany, and Taiwan.